Autres langues genedrive plc

Actions

EHP

GB00B1VKB244

Equipement et technologie médicale avancés

Temps Différé London S.E. 11:53:54 24/09/2026			Varia. 5j.	Varia. 1 janv.
1,225 ^GBX	+2,07%		-2,02%	+39,98%

10/09	Genedrive PLC, Betsi Cadwaladr University Health Board et Cardiff and Vale University Health Board pérennisent l'utilisation clinique du test Genedrive MT-RNR1	CI
03/09	Transcript : Genedrive plc - Shareholder/Analyst Call

Autres langues

16/09	Genedrive : Scottish Stroke Nurses Forum
10/09	Genedrive PLC, Betsi Cadwaladr University Health Board, and Cardiff and Vale University Health Board Extend Routine Clinical Service of Genedrive MT-RNR1 Test
21/08	Genedrive plc Announces Board Appointments, Effective September 1, 2026
11/08	Redcentric buyback progamme; Synectics product launch
11/08	Genedrive Finalizes UK Patient Enrollment for Rapid Pharmacogenetic Test
11/08	Genedrive plc Completes PALOH-UK Patient Recruitment For Genedrive MT-RNR1 ID Kit
04/08	EARNINGS AND TRADING: MedPal AI celebrates "record" July trading
04/08	Miners shine as FTSE stays in the green
04/08	Genedrive Implements Genedrive MT-RNR1 ID Kit At Erasmus MC University Medical Center In The Netherlands
03/08	Genedrive plc Announces New Uk Clinical Guideline for Mt-Rnr1 Genotype Testing
30/07	WINNERS & LOSERS: Vanquis cuts outlook; Zoo Digital loss narrows
17/07	WINNERS & LOSERS: Itaconix revenue rises; Alumasc suspends CEO
14/07	EXECUTIVE CHANGES: Ian Cheshire gives up Spire chair for Ofcom post
14/07	Genedrive plc Appoints Graham Cole CBE as Chair and an Independent Non-Executive Director with Effect from 14 July 2026
14/07	Genedrive Names New Chair
13/07	Zenith Energy in Rome buy; Concurrent revenue rises
13/07	WINNERS & LOSERS: Ixico lower order book; Pennant sees revenue jump
13/07	Genedrive plc Earnings Revenue Guidance for the Fiscal Year 2026
10/07	Sancus Lending names Andrew Charnley as new CEO
10/07	WINNERS & LOSERS: Safestay jumps on possible offer; LPA wins contracts
10/07	Genedrive Announces Adoption of Genedrive Mt-Rnr1 Id Kit for Rapid Pharmacogenetic Testing in Nhs Neonatal Intensive Care Units
02/07	Genedrive plc Announces Termination of Thomas Lindsay from Director, Effective March 31, 2026
01/07	EXECUTIVE CHANGES: AB Dynamics appoints CFO; Physiomics names new COO
01/07	Genedrive Chairman Steps Down
29/06	Genedrive plc And Thermo Fisher Scientific Inc Enters Collaboration Agreement For CYP2C19 Product Development